Bioavailability Systems LLC is an emerging biopharmaceutical company focused on developing applications for our potent cytochrome P450 3A inhibitors to enhance the therapeutic and pharmacoeconomic benefits of oral pharmaceuticals. BAS was founded in 1996 by James W. Harris, PhD and Robert A. Baugher as a limited liability company incorporated in Maryland.